Colirio Eyemo

Quick links to important sections

Colirio Eyemo

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Colirio Eyemo

Quick Facts: Colirio Eyemo Identity

Property Description
Active ingredient Tetryzoline (Tetrahydrozoline hydrochloride)
Form Ophthalmic Solution (Eye drops)
Pharmacological class Ophthalmic Decongestant
Common use Reduction of Ocular Redness (Hyperemia)
Origin Synthetic (Imidazoline derivative)

What Type of Medicine is Colirio Eyemo?

Colirio Eyemo is a pharmaceutical preparation classified as an Ophthalmic Decongestant, designed for Topical Administration to the eye surface. It belongs to the broader pharmacological group of Sympathomimetic Amines and is chemically defined as an Imidazoline derivative. The drug is a monosemantic, synthetic compound that is often positioned as an over-the-counter (OTC) agent for general public use. Tetryzoline-containing preparations are primarily used to provide relief from minor irritation and redness of the eye.

Tetryzoline: Composition and Pharmaceutical Form

The single active ingredient within Colirio Eyemo is Tetryzoline (Tetrahydrozoline hydrochloride), which is responsible for the product's therapeutic effect. This medication is prepared as a sterile Ophthalmic Solution, commonly known as eye drops, suspended in an Aqueous Vehicle base. The formulation as a solution is optimized for rapid contact with the ocular surface. The mechanism of action is specifically linked to alpha-adrenergic receptor activation, a process that causes localized vasoconstriction. The International Nonproprietary Name (INN) for the active substance is Tetryzoline.

What is the General Purpose of Colirio Eyemo?

The general purpose of Colirio Eyemo is to achieve localized conjunctival decongestion by acting as a powerful Vasoconstrictor. Tetryzoline functions as an alpha1-adrenergic agonist, signaling the small blood vessels on the conjunctiva to constrict. This effect diminishes the appearance of engorged capillaries, thereby providing symptomatic relief by reducing visible ocular redness (hyperemia). This symptomatic effect is particularly sought in everyday scenarios, such as when eyes appear red due to environmental factors or minor irritants. This action is purely symptomatic, strictly focusing on the visual sign of congestion rather than treating any underlying cause.

Regulatory References

  1. Tetrahydrozoline Ophthalmic: MedlinePlus Drug Information
  2. Tetryzoline: Uses, Interactions, Mechanism of Action | DrugBank Online

What side effects are possible with Colirio Eyemo?

Possible Side Effects and Safety Information

The safety profile for Colirio Eyemo (containing naphazoline) describes both common, local reactions and rare, serious risks associated with improper use or ingestion, as documented in regulatory sources.

Common or Expected Ocular Reactions

Adverse effects listed under general frequency classifications are typically mild, transient, and occur at the application site. These include:

  • Temporary stinging or burning sensation
  • Ocular irritation or discomfort
  • Mild, temporary blurred vision
  • Pupillary dilation (mydriasis)

Serious Adverse Reactions and Systemic Risk

The most significant safety warnings relate to the risk of systemic toxicity from accidental swallowing, especially by young children. Regulatory documents note that ingestion can lead to severe Central Nervous System (CNS) depression, potentially causing coma, marked reduction in body temperature, and dangerous changes in heart rate. Systemic absorption following overdose may also lead to severe low blood pressure or hypertensive crisis.

Population-Specific and Use-Related Safety Constraints

Official labeling defines specific restrictions and cautions for use:

  • Contraindications: The product is strictly restricted for use in individuals with narrow-angle glaucoma and those with a documented hypersensitivity to the ingredients.
  • Pediatrics: Use is generally not recommended in infants and children due to the high risk of serious systemic toxicity from accidental ingestion.
  • Duration of Use: Regulatory information warns that prolonged or excessive use may lead to rebound hyperaemia (worsening redness) upon discontinuation of the product. Use is often limited to a maximum of 72 hours.
  • Caution Required: Patients with pre-existing conditions such as hypertension, hyperthyroidism, or diabetes mellitus must exercise caution due to the potential for systemic absorption.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents state that Tetryzoline overdose presents as systemic toxicity, which occurs primarily after accidental oral ingestion. Overdose manifestations are classified as serious and life-threatening adverse events.

Documented Overdose Manifestations

Overdose may involve severe effects on the Central Nervous System (CNS), resulting in manifestations of CNS depression, including lethargy, drowsiness, stupor, and in severe cases, coma. It can also significantly impact the Cardiovascular System, leading to changes such as bradycardia (slow heart rate) and hypotension (low blood pressure). The most severe outcomes documented in regulatory sources include respiratory depression or apnea (absent breathing).

When to Seek Urgent Medical Help

Regulatory authorities explicitly warn that young children, particularly those aged five and younger, are the most vulnerable population, as the ingestion of a small amount (documented as 1 to 2 mL) can trigger these serious systemic effects. In any instance of suspected overdose or accidental ingestion, the official guidance mandates that individuals seek immediate medical attention. Specific instruction requires the patient or caregiver to call a doctor or Poison Control Center right away and seek emergency medical care immediately.

Supportive Management

The management approach described in official labeling is symptomatic and supportive treatment. Airway support, intravenous fluids, and activated charcoal are listed among the possible procedural measures. It is formally stated that no specific antidote is known for Tetryzoline poisoning.

Therapeutic Uses of Colirio Eyemo

What Colirio Eyemo Treats: Main Uses and Benefits

This medication may be part of symptomatic management for visible eye redness (a bloodshot appearance) and associated minor discomfort. The use of this active ingredient is relevant within the therapeutic area of redness relief, particularly for easing symptoms related to inflammatory or irritative states. The therapeutic domains primarily involve providing relief from the symptomatic cluster of minor itching, burning, and irritation. This use is generally applied in contexts where additional symptomatic support is needed.

Easing Symptoms and Supporting Comfort

Colirio Eyemo may assist with managing symptoms often linked to common external factors like dust, smoke, wind, or eye strain. This use is applicable in conditions characterized by periods of heightened symptoms that may temporarily interfere with daily functioning. By providing supportive relief, the drops contribute to a soothing effect and help the eye's clear look. The drops are used in situations that involve short-term symptomatic assistance when minor eye irritation and discomfort become noticeable.

“The drops are relevant when supportive symptom management is appropriate during acute or disruptive episodes.”

Quick Fact: Symptomatic Support The drops are commonly used when symptoms intensify and short-term assistance is needed, supporting comfort during acute, episodic changes.

Eligibility and Restrictions for Use

Who Can and Cannot Use Colirio Eyemo?

The population eligibility for Colirio Eyemo (Tetryzoline ophthalmic solution) is strictly defined by regulatory documents, outlining populations who are permitted to use the medicine and those who must not.

Absolute Non-Eligibility (Contraindications)

Individuals must not use this medicine if they have narrow-angle glaucoma, a known hypersensitivity to the formulation, or if they are currently taking or have recently discontinued Monoamine Oxidase Inhibitors (MAOIs).

Age-Related and Conditional Restrictions

Age Eligibility

Population Regulatory Status
Children Under 6 Years Use is not established.
Adolescents and Adults Permitted for standard self-medication use.

Conditional Use

Use requires caution or professional consultation in patients with certain comorbidities, including Hypertension, heart disease, Diabetes Mellitus, Hyperthyroidism, Phaeochromocytoma, or prostatic hypertrophy.

Pregnancy and Lactation

Regulatory labeling requires that a health professional be consulted before using the medicine during both pregnancy and breastfeeding.

What should I know about interactions with other medicines?

The official regulatory profile for Colirio Eyemo (Tetryzoline ophthalmic) establishes clear restrictions regarding its use alongside certain medicinal products. Tetryzoline, a sympathomimetic agent, carries a formal contraindication for co-administration with Monoamine Oxidase Inhibitors (MAOIs), as well as with other agents, such as Furazolidone, that possess MAOI activity.

This restriction is based on the potential for an additive pressor effect, where the combination of these substances could lead to an augmented cardiovascular response. The profile imposes a timing-based interaction rule for safety. The ophthalmic solution must not be used until at least 14 days have passed after discontinuing treatment with an MAOI. This 14-day separation is required to mitigate the classified risk.

Regarding other substances, official interaction information states that there are no known interactions with common foods or drinks. The potential effect of combining the product with alcohol is currently classified as unknown in regulatory documents. No population-specific interaction adjustments are explicitly documented within the official interaction sections. The resulting structure prioritizes the prohibition of combinations that risk an augmented cardiovascular response due to the product’s sympathomimetic properties.

Mechanism of Action

Selective alpha1-Adrenergic Receptor Targeting

The mechanism of Tetryzoline is centered on its action as a selective agonist of the Alpha-1 (alpha1) adrenergic receptors found predominantly on the smooth muscle of conjunctival blood vessels. This interaction initiates a signaling cascade, mimicking the body's natural sympathetic pathway to directly engage the neurovascular system.


Modulation of Conjunctival Vascular Tone

Activation of these receptors leads to increased intracellular calcium, which forces the surrounding vascular smooth muscle cells to contract, a process known as vasoconstriction. This core action locally controls the blood vessel diameter, leading to a physiological reduction of localized blood volume and a consequential decrease in vascular engorgement.


Constraint: Tachyphylaxis and Functional Limitation

The function of the mechanism is biologically constrained by tachyphylaxis, a process where sustained receptor activation causes desensitization and diminished responsiveness over time. This limitation can result in rebound vasodilation upon cessation, and it underscores that the mechanism only addresses the physiological state of vessel dilation, not the underlying inflammatory cause.

Dosage and Administration Information

Administration Guidelines

Colirio Eyemo (Tetrahydrozoline hydrochloride 0.05% ophthalmic solution) is strictly for topical ophthalmic use and must not be administered systemically or via injection. All usage must adhere to the standard instructions for the product.


Feature Labeled Instruction
Route of Administration Topical to the eye surface (Ophthalmic)
Dosing Schedule 1 to 2 drops in the affected eye(s) per administration
Frequency Used as needed (PRN), up to a maximum of four times daily
Duration Constraint Continuous self-medication must not exceed 72 hours (3 days)

Age-Specific Use and Procedural Protocols

The standard 1 to 2 drop regimen is for adults and children 6 years of age and older. Use in children under 6 years requires consultation with a healthcare professional.

Several procedural rules apply for correct application: The solution must be checked for clarity; it should not be used if cloudy or discolored. To prevent contamination, the container tip must not touch the eye, eyelid, or any other surface during instillation. Additionally, patients who wear soft contact lenses must remove the lenses before administration and wait a minimum of 15 minutes before re-inserting them.

The application protocol defines the standardized, short-term, as-needed use for the ophthalmic solution, limiting both the frequency of daily use and the total duration of continuous self-medication.

Recent Clinical Evidence

Evidence for Use in Temporary Relief of Ocular Redness and Minor Irritation

The primary component, Tetryzoline (the active ingredient in Colirio Eyemo), was studied for research exploring how symptoms change over time related to temporary eye redness (hyperemia) and minor irritation. Its evidence base includes Regulatory Reviews and Short-Term Randomized Controlled Trials (RCTs) designed to objectively measure changes in eye appearance. Researchers examined metrics like Ocular Redness Scores alongside patient-reported outcomes describing perceived discomfort. Studies monitored a temporary change in the appearance of blood vessels on the eye's surface, a physiological pattern described in relation to visible redness.

Comparative Studies and Context of Evidence

The evidence base includes research where Tetryzoline was evaluated in settings that compare its effect against a non-medicated eye drop (placebo). The data show patterns related to Onset and Duration of Vasoconstriction. The overall level of evidence related to the short-term, symptomatic use of this ingredient is classified as Moderate; this reflects the nature of studies and the ingredient’s established regulatory acceptance.

Long-Term Follow-up and Duration of Assessment

The available clinical research is generally limited to Acute/Short-Term studies, which focused on immediate effects and utilization periods up to 72 hours. Research exploring short-term symptom changes monitored how long the effect was observed, with many describing the duration of the vasoconstrictive effect as a limited number of hours. Long-term effects are not fully established, and there is limited information regarding the potential outcomes of chronic or excessive use.

Evidence in Specific Population Groups

The majority of clinical data and results apply only to the populations studied, which consist primarily of generally healthy Adults and Adolescents (age 5 years and older). Data for certain groups remain insufficient. Few data are available from studies specifically focused on the therapeutic profile and usage patterns in the older adult population. Findings describe group patterns, not personal outcomes.

Research Gaps and Unanswered Questions

Key limitations in the research include the fact that the medicine's studied action is Symptomatic-Only, meaning research explored the symptomatic change but did not monitor the active ingredient for outcomes related to the underlying cause of irritation. Research monitored patterns of Rebound Redness (where hyperemia increases after the effect wears off); this observation highlights an area to be explored in future research. Long-term effects are not fully established and more research is needed to understand all long-term usage patterns.

Key Studies & References Tetrahydrozoline Ophthalmic: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Colirio Eyemo (FAQ)


Q: Is Colirio Eyemo the same as Visine or other common eye drops?

Colirio Eyemo contains the active ingredient Tetryzoline (Tetrahydrozoline hydrochloride), which is classified as a redness reliever. This same active ingredient is found in several other common, over-the-counter ophthalmic decongestant products, including products known by other brand names.


Q: Can Colirio Eyemo be used for dry eyes or only for redness?

According to official product information, the primary use of Tetryzoline is for the temporary relief of ocular redness (hyperemia) and discomfort due to minor irritations. The product is not specifically indicated for the treatment of dry eyes. Lubricating eye drops, which contain different active ingredients, are generally used for that purpose.


Q: Why does my vision seem slightly blurry right after I put in Colirio Eyemo?

Temporary blurred vision is listed in regulatory documents as a potential common, transient side effect of the medicine. This effect is associated with the medicine’s ability to cause temporary pupillary dilation (mydriasis), which is noted in regulatory information.


Q: What is the difference between Colirio Eyemo and a lubricating eye drop?

Colirio Eyemo is classified as an Ophthalmic Decongestant because it uses the active ingredient Tetryzoline to constrict blood vessels and reduce redness. A pure lubricating eye drop is classified as a demulcent and typically contains ingredients used to relieve dry eyes and discomfort by moisturizing the eye surface. These drops do not contain the active redness-relieving agent found in Colirio Eyemo.


Q: Does Colirio Eyemo contain preservatives, and is that a concern?

Many formulations of Tetryzoline eye drops contain a preservative, such as Benzalkonium Chloride, which is listed in the inactive ingredients. Official regulatory labels list the preservative, but do not provide specific guidance on this being a general concern.


Q: Does Colirio Eyemo expire, and can I use it past the expiration date?

Yes, Colirio Eyemo, like all medications, has a documented expiration date on the packaging. General guidance recommends consulting a pharmacist or health caregiver about the proper method for disposal of expired or unused products.


Q: Can I put Colirio Eyemo in my refrigerator?

Regulatory documents indicate the product must be stored at controlled room temperature, typically between 15^circC and 30^circC (59^circF and 86^circF). The label explicitly warns, 'Do not freeze,' and does not recommend storing the product in the refrigerator.


Q: What are the inactive ingredients in Colirio Eyemo?

According to regulatory sources, the inactive ingredients for Tetryzoline solutions often include substances necessary for stability and formulation, such as Purified Water, Boric Acid, Sodium Chloride, Edetate Disodium, and Sodium Borate, plus a preservative like Benzalkonium Chloride.


Q: Does Colirio Eyemo have an effect on eye pressure?

The product is contraindicated (restricted) for use in individuals with narrow-angle glaucoma due to the risk that the pupillary dilation effect may impact intraocular pressure in those specific cases. This restriction is mandated by regulatory bodies.


Q: Are there generic versions of Colirio Eyemo available?

Yes, the active ingredient Tetryzoline is widely available. Regulatory product listings show that this ingredient is found under multiple brand names, as well as numerous store-brand or generic labels, which are all classified as over-the-counter drugs.


Q: Is Colirio Eyemo effective for bloodshot eyes caused by lack of sleep?

The drug is indicated for the temporary relief of redness of the eye due to minor eye irritations. Although the label does not explicitly list 'lack of sleep' as an indication, the ingredient's action is on the visible symptom of redness.


Q: Does exposure to light affect how Colirio Eyemo works?

Official storage information indicates the product should be Protected from excessive heat and light to maintain its quality and stability. Following these guidelines is necessary for the product to function as intended.


Q: What are the potential side effects if I accidentally swallow a small amount of Colirio Eyemo?

In the event of accidental swallowing, the regulatory warning is to immediately contact a Poison Control Center or seek medical attention, as ingestion, even of a small amount, carries a risk of serious systemic toxicity.


Q: Is it safe to share Colirio Eyemo with another family member?

Regulatory labeling cautions users to avoid contamination by not touching the container tip to any surface. Sharing eye drop dispensers is generally discouraged to help prevent the risk of transferring contamination from one person to another.


Q: Does Colirio Eyemo contain an antihistamine?

No, the active ingredient in Colirio Eyemo is Tetryzoline, which is classified as an Ophthalmic Decongestant (redness reliever). The product is not formulated with an antihistamine, which would be a separate type of active ingredient used to treat allergic symptoms.


Q: Can using Colirio Eyemo cause photophobia (light sensitivity)?

Pupillary dilation (mydriasis) is listed as a potential side effect. This change in pupil size may be associated with increased sensitivity to light (photophobia), though photophobia itself is not always listed as a direct side effect.


Q: Is it okay if I miss a dose of Colirio Eyemo and just take it when I remember?

The product is intended for use as needed for temporary relief, up to the maximum daily frequency specified on the label. Usage should be guided by the 'as needed' indication and should not exceed the daily limit.

How should Colirio Eyemo be stored and disposed of?

How to Store and Dispose of Colirio Eyemo

Colirio Eyemo (Tetryzoline ophthalmic solution) must be stored according to specific regulatory requirements to maintain its stability and sterility.

Storage Conditions

Item Requirement
Temperature Store at controlled room temperature between 15 C and 30 C (59 F and 86 F).
Handling/Stability Do not freeze and avoid excessive heat or moisture. Do not use if the solution changes color or becomes cloudy.
Container Integrity Keep the bottle tightly closed and replace the cap immediately after use. Do not touch the container tip to any surface.

Safety and Disposal

The medicine must be kept out of the sight and reach of children. If the solution is accidentally swallowed, immediately contact a Poison Control Center or get medical help.

For disposal of expired or unused product, you should ask a pharmacist or health caregiver about the proper method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Colirio Eyemo found in:

A-Z Index: